|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.35 USD | -0.46% |
|
-5.47% | -10.13% |
| May. 23 | Some of the biggest splits in Corporate America | RE |
| May. 22 | Cancer victims sue Johnson & Johnson over 'fraudulent' bankruptcies | RE |
May 13 (Reuters) - Tylenol maker Kenvue said on Monday that Johnson & Johnson will offload its entire 9.5% stake in the company, about a year after the healthcare conglomerate spun off and listed its consumer health business.
Shares of Kenvue fell nearly 4% in premarket trading.
Based on the stock's last close, the offering would be worth about $3.75 billion, according to Reuters calculation.
(Reporting by Leroy Leo in Bengaluru; Editing by Shilpi Majumdar and Sriraj Kalluvila)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 147 USD | -1.82% | -4.96% | 354B | ||
| 19.35 USD | -0.46% | -5.47% | 37.05B | ||
| 1st Jan change | Capi. | |
|---|---|---|
| -10.13% | 37.05B | |
| +12.82% | 390B | |
| +13.05% | 137B | |
| +17.05% | 76.55B | |
| -10.50% | 67.04B | |
| -13.81% | 45.2B | |
| +7.52% | 35.52B | |
| +9.04% | 18.02B | |
| +17.48% | 16.14B | |
| +1.83% | 11.91B |
KENVUE INC. 
